JP2001510793A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001510793A5 JP2001510793A5 JP2000503829A JP2000503829A JP2001510793A5 JP 2001510793 A5 JP2001510793 A5 JP 2001510793A5 JP 2000503829 A JP2000503829 A JP 2000503829A JP 2000503829 A JP2000503829 A JP 2000503829A JP 2001510793 A5 JP2001510793 A5 JP 2001510793A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- methyl
- carbon atoms
- transplantation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001789A IT1293795B1 (it) | 1997-07-28 | 1997-07-28 | Farmaco attivo nel ridurre la produzione di proteina mcp-1 |
| IT97A01789 | 1997-07-28 | ||
| PCT/EP1998/004924 WO1999004770A2 (en) | 1997-07-28 | 1998-07-22 | A pharmaceutical composition active in reducing production of mcp-1 protein |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009270715A Division JP5086322B2 (ja) | 1997-07-28 | 2009-11-09 | Ｍｃｐ−１プロテインの増加生産によって特徴付けられる障害の処置のための薬剤組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001510793A JP2001510793A (ja) | 2001-08-07 |
| JP2001510793A5 true JP2001510793A5 (enExample) | 2006-01-05 |
| JP4651191B2 JP4651191B2 (ja) | 2011-03-16 |
Family
ID=11377642
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000503829A Expired - Fee Related JP4651191B2 (ja) | 1997-07-28 | 1998-07-22 | Ｍｃｐ−１タンパク質の生成を減らす際に活性がある薬剤組成物 |
| JP2009270715A Expired - Fee Related JP5086322B2 (ja) | 1997-07-28 | 2009-11-09 | Ｍｃｐ−１プロテインの増加生産によって特徴付けられる障害の処置のための薬剤組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009270715A Expired - Fee Related JP5086322B2 (ja) | 1997-07-28 | 2009-11-09 | Ｍｃｐ−１プロテインの増加生産によって特徴付けられる障害の処置のための薬剤組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6534534B1 (enExample) |
| EP (1) | EP1005332B1 (enExample) |
| JP (2) | JP4651191B2 (enExample) |
| AR (1) | AR016382A1 (enExample) |
| AT (1) | ATE251902T1 (enExample) |
| AU (1) | AU744492B2 (enExample) |
| CA (1) | CA2300289C (enExample) |
| DE (1) | DE69819012T2 (enExample) |
| DK (1) | DK1005332T3 (enExample) |
| ES (1) | ES2207858T3 (enExample) |
| IT (1) | IT1293795B1 (enExample) |
| PT (1) | PT1005332E (enExample) |
| SI (1) | SI1005332T1 (enExample) |
| WO (1) | WO1999004770A2 (enExample) |
| ZA (1) | ZA986636B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1293795B1 (it) * | 1997-07-28 | 1999-03-10 | Angelini Ricerche Spa | Farmaco attivo nel ridurre la produzione di proteina mcp-1 |
| US7238711B1 (en) | 1999-03-17 | 2007-07-03 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
| ITMI20062254A1 (it) | 2006-11-24 | 2008-05-25 | Acraf | Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca |
| GEP20135913B (en) * | 2008-03-07 | 2013-08-26 | Acraf | 1-benzyl-3-hydroxymethylindazole derivatives and use thereat treatment of diseases based on mcp-1 and cx3cr1 expression |
| PL2254870T3 (pl) * | 2008-03-07 | 2016-07-29 | Acraf | Pochodne 1-benzylo-3-hydroksymetyloindazolu i ich zastosowanie w leczeniu chorób opartych na ekspresji MCP-1, CX3CR1 |
| MX2010009625A (es) * | 2008-03-07 | 2010-09-28 | Acraf | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40. |
| DK2462118T3 (da) | 2009-08-03 | 2014-08-25 | Acraf | Fremgangsmåde til fremstilling af 1-benzyl-3-hydroxymethyl-1H-indazol og dets derivater og nødvendige magnesiummellemprodukter |
| UA108742C2 (uk) * | 2009-09-23 | 2015-06-10 | Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1 | |
| GB2550526B (en) | 2010-02-25 | 2018-02-07 | Prairie Ventures Llc | System and method for anatomical pathology sample handling, storage, and analysis |
| US8999292B2 (en) | 2012-05-01 | 2015-04-07 | Translatum Medicus Inc. | Methods for treating and diagnosing blinding eye diseases |
| DK3142664T3 (da) * | 2014-05-15 | 2020-03-09 | Translatum Medicus Inc | Sammensætninger og fremgangsmåder til behandling og diagnosticering af øjensygdomme |
| AU2016277126A1 (en) | 2015-06-12 | 2017-12-14 | Vettore, LLC | MCT4 inhibitors for treating disease |
| KR102615828B1 (ko) | 2016-12-12 | 2023-12-20 | 베토어 엘엘씨 | Mct4 의 헤테로시클릭 저해제 |
| EP3990433A4 (en) | 2019-06-25 | 2023-07-26 | Translatum Medicus Inc. | METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1230441B (it) * | 1989-02-07 | 1991-10-23 | Acraf | Eteri della serie dell'indazolo |
| US5100899A (en) * | 1989-06-06 | 1992-03-31 | Roy Calne | Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
| IT1253703B (it) * | 1991-04-22 | 1995-08-23 | Angelini Francesco Ist Ricerca | Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie |
| AU5537994A (en) * | 1992-10-22 | 1994-05-09 | Mallinckrodt Medical, Inc. | Therapeutic treatment for inhibiting vascular restenosis |
| US5563145A (en) * | 1994-12-07 | 1996-10-08 | American Home Products Corporation | Rapamycin 42-oximes and hydroxylamines |
| JPH08333262A (ja) * | 1995-04-07 | 1996-12-17 | Chugai Pharmaceut Co Ltd | 免疫抑制剤 |
| US6113898A (en) * | 1995-06-07 | 2000-09-05 | Idec Pharmaceuticals Corporation | Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies |
| DE19538402A1 (de) * | 1995-10-14 | 1997-04-17 | Boehringer Mannheim Gmbh | Lipidalkohole als neue immunsuppressive und antivirale Arzneimittel |
| JPH09165339A (ja) * | 1995-10-27 | 1997-06-24 | American Home Prod Corp | ラパマイシンを付与したドナー脾細胞を用いる臓器移植の延長 |
| IT1276031B1 (it) * | 1995-10-31 | 1997-10-24 | Angelini Ricerche Spa | Composizione farmaceutica per il trattamento delle malattie autoimmuni |
| US5780462A (en) * | 1995-12-27 | 1998-07-14 | American Home Products Corporation | Water soluble rapamycin esters |
| IT1293795B1 (it) * | 1997-07-28 | 1999-03-10 | Angelini Ricerche Spa | Farmaco attivo nel ridurre la produzione di proteina mcp-1 |
-
1997
- 1997-07-28 IT IT97MI001789A patent/IT1293795B1/it active IP Right Grant
-
1998
- 1998-07-22 DE DE69819012T patent/DE69819012T2/de not_active Expired - Lifetime
- 1998-07-22 SI SI9830573T patent/SI1005332T1/xx unknown
- 1998-07-22 EP EP98943862A patent/EP1005332B1/en not_active Expired - Lifetime
- 1998-07-22 AT AT98943862T patent/ATE251902T1/de active
- 1998-07-22 DK DK98943862T patent/DK1005332T3/da active
- 1998-07-22 CA CA002300289A patent/CA2300289C/en not_active Expired - Fee Related
- 1998-07-22 PT PT98943862T patent/PT1005332E/pt unknown
- 1998-07-22 JP JP2000503829A patent/JP4651191B2/ja not_active Expired - Fee Related
- 1998-07-22 WO PCT/EP1998/004924 patent/WO1999004770A2/en not_active Ceased
- 1998-07-22 AU AU91601/98A patent/AU744492B2/en not_active Ceased
- 1998-07-22 US US09/463,666 patent/US6534534B1/en not_active Expired - Lifetime
- 1998-07-22 ES ES98943862T patent/ES2207858T3/es not_active Expired - Lifetime
- 1998-07-24 ZA ZA986636A patent/ZA986636B/xx unknown
- 1998-07-28 AR ARP980103695A patent/AR016382A1/es unknown
-
2009
- 2009-11-09 JP JP2009270715A patent/JP5086322B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001510793A5 (enExample) | ||
| Moskowitz et al. | Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit | |
| CY1109449T1 (el) | Ενωσεις ουριας δραστικες ως ανταγωνιστες βανιλλοειδων υποδοχεων για την αντιμετωπιση του πονου | |
| DE60128258D1 (de) | Indanylderivate zur Behandlung von Atemwegserkrankungen | |
| EP1159964A3 (en) | Compositions and methods for stimulating gastrointestinal motility | |
| EP1422217A3 (en) | Aminocyclohexyl ether compounds and uses thereof | |
| EP1797878A3 (en) | Benzothiazole derivatives | |
| JP2002525323A5 (enExample) | ||
| EP0709376A3 (en) | Therapeutic compounds | |
| JP2002518502A5 (enExample) | ||
| EP2210892A3 (en) | Neurologically-active compounds | |
| Neu | Segmental bone and cartilage reconstruction of major nasal dorsal defects | |
| BR0210122A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo | |
| GB9900334D0 (en) | Tricylic vascular damaging agents | |
| JP2002543202A5 (enExample) | ||
| EP1891954A3 (en) | Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder | |
| Zimmerman et al. | Examination of an Aleutian mummy | |
| EP0992509A3 (en) | Novel macrolide derivatives | |
| EP1431286A3 (en) | Prodigiosin derivatives for treating cancer or viral diseases | |
| EP2364708A3 (en) | Pharmaceutical composition comprising a ClC-2 channel opener | |
| IS7908A (is) | Ný notkun dextransúlfats | |
| JP2001510793A (ja) | Ｍｃｐ−１タンパク質の生成を減らす際に活性がある薬剤組成物 | |
| Ritsilä et al. | Reconstruction of experimental tracheal cartilage defects with free periosteum: a preliminary report | |
| van Susante et al. | Potential healing benefit of an osteoperiosteal bone plug from the proximal tibia on a mosaicplasty donor-site defect in the knee: an experimental study in the goat | |
| PT941110E (pt) | Utilizacao do factor 2 de crescimento dos ceratinocitos |